ea0011oc23 | Clinical endocrinology | ECE2006
Ardill JES
, Johnston BJ
, Turner GB
, McGinty A
, McCance DR
Midgut Carcinoid disease (MGC) is uncommon, occurring in approximately 1.4 per 100,000 of the population per year. MGC has an unpredictable disease progression varying from rapid and aggressive to slow and indolent. For this reason it is not appropriate to treat all patients according to the same schedule. As some treatments are not without risk, it is important to identify those patients selected for these options at an appropriate stage of disease.In a...